Case Name |
Date Filed |
Judge |
Drug |
Patent No(s). |
Celgene Corp. v. Mylan Pharms. Inc., 20-0003 (N.D.W.V.) |
Jan. 3, 2020 |
Hon. Irene M. Keeley |
Revlimid® (lenalidomide capsules) |
7,189,740
7,465,800
7,855,217
7,968,569
8,404,717
8,530,498
8,648,095
9,056,120
9,101,621
9,101,622 |
Exela Pharma Sciences, LLC v. Avadel Legacy Pharms., LLC, 20-0024 (D. Del.) |
Jan. 7, 2020 |
Hon. Maryellen Noreika |
Elcys® (cysteine HCl for injection) Nouress™ (cysteine HCl for injection) |
10,478,453 |
Celgene Corp. v. Aurobindo Pharma Ltd., 20-0315 (D.N.J.) |
Jan. 8, 2020 |
Hon. Susan D. Wigenton |
Revlimid® (lenalidomide capsules) |
7,465,800
7,855,217
7,968,569
8,530,498
8,648,095
9,101,621
9,101,622 |
Almirall, LLC v. Zydus Pharms. (USA) Inc., 20-0343 (D.N.J.) |
Jan. 9, 2020 |
Hon. Freda L. Wolfson |
Aczone® (dapsone gel) |
9,517,219 |
Almirall, LLC v. Mylan Pharms. Inc., 20-0006 (N.D.W.V.) |
Jan. 9, 2020 |
Hon. Irene M. Keeley |
Aczone® (dapsone gel) |
9,517,219 |
Amgen Inc. v. Torrent Pharma Inc., 20-0065 (D. Del.) |
Jan. 16, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 20-0534 (D.N.J.) |
Jan. 16, 2020 |
Hon. Claire C. Cecchi |
Dificid® (fidaxomicin tablets) |
7,906,489
8,586,551
7,378,508
7,863,249
8,859,510 |
Novartis Pharms. Corp. v. Alembic Pharms. Ltd., 20-0074 (D. Del.) |
Jan. 17, 2020 |
Hon. Leonard P. Stark |
Entresto® (sacubitril / valsartan tablets) |
8,101,659
8,796,331
8,877,938
9,388,134 |
Amgen Inc. v. Zydus Pharms. (USA) Inc., 20-0075 (D. Del.) |
Jan. 17, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 20-20217 (S.D. Fla.) |
Jan. 17, 2020 |
Hon. Ursula Ungaro |
Dificid® (fidaxomicin tablets) |
7,906,489
8,586,551
7,378,508
7,863,249
8,859,510 |
Vanda Pharms. Inc. v. Apotex Inc., 20-0083 (D. Del.) |
Jan. 21, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,449,176 |
Amgen Inc. v. Zydus Pharms. (USA) Inc., 20-0678 (D.N.J.) |
Jan. 21, 2020 |
Hon. Freda L. Wolfson |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Vanda Pharms. Inc. v. Teva Pharms. USA, Inc., 20-0093 (D. Del.) |
Jan. 22, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,449,176 |
Amgen Inc. v. Bionpharma, Inc., 20-0105 (D. Del.) |
Jan. 23, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Relypsa, Inc. v. Alkem Labs. Ltd., 20-0106 (D. Del.) |
Jan. 23, 2020 |
Hon. Maryellen Noreika |
Veltassa® (patiromer sorbitex calcium powder for oral suspension) |
8,337,824
9,492,476
9,925,212 |
Merck Sharp & Dohme Corp. v. Sandoz Inc., 20-0783 (D.N.J.) |
Jan. 23, 2020 |
Hon. Brian R. Martinotti |
Noxafil® (posaconazole oral suspension) |
8,263,600 |
Janssen Products, L.P. v. Zydus Pharms. (USA) Inc., 20-0787 (D.N.J.) |
Jan. 23, 2020 |
Hon. Freda L. Wolfson |
Prezista® (darunavir tablets) |
7,700,645
8,518,987
7,126,015
7,595,408 |
Amgen Inc. v. Annora Pharma Private Ltd., 20-0122 (D. Del.) |
Jan. 24, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Amgen Inc. v. Centaur Pharms. Private Ltd., 20-0123 (D. Del.) |
Jan. 24, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Novartis Pharms. Corp. v. Apotex Inc., 20-0133 (D. Del.) |
Jan. 28, 2020 |
Hon. Leonard P. Stark |
Gilenya® (fingolimod capsules) |
10,543,179 |
Sucampo Gmbh v. Zydus Pharms. (USA) Inc., 20-0936 (D.N.J.) |
Jan. 28, 2020 |
Hon. Freda L. Wolfson |
Amitiza® (lubiprostone capsules) |
7,795,312
8,026,393
8,338,639
8,779,187
8,748,481 |
Amgen Inc. v. MSN Pharms., Inc., 20-0137 (D. Del.) |
Jan. 29, 2020 |
Hon. Colm F. Connolly |
Corlanor® (ivabradine tablets) |
7,361,649
7,361,650
7,867,996
7,879,842 |
Pfizer Inc. v. Viwit Pharm. Co., Ltd., 20-0160 (D. Del.) |
Jan. 31, 2020 |
Hon. Colm F. Connolly |
Chantix® (varenicline tartrate tablets) |
6,410,550
6,890,927
7,265,119 |
Silvergate Pharms., Inc. v. CMP Development LLC, 20-0161 (D. Del.) |
Jan. 31, 2020 |
Hon. Leonard P. Stark |
Qbrelis® (Lisinopril oral solution) |
9,463,183
9,616,096
9,814,751
10,039,800
10,265,370
10,406,199 |
GlaxoSmithKline Consumer Healthcare Holdings (US), LLC v. Cipla Ltd., IPR2020-00368 (PTAB) |
Jan. 31, 2020 |
N/A |
Dymista® (azelastine HCl / fluticasone propionate metered spray) |
8,163,723 |
GlaxoSmithKline Consumer Healthcare Holdings (US), LLC v. Cipla Ltd., IPR2020-00369 (PTAB) |
Jan. 31, 2020 |
N/A |
Dymista® (azelastine HCl / fluticasone propionate metered spray) |
8,168,620 |
GlaxoSmithKline Consumer Healthcare Holdings (US), LLC v. Cipla Ltd., IPR2020-00370 (PTAB) |
Jan. 31, 2020 |
N/A |
Dymista® (azelastine HCl / fluticasone propionate metered spray) |
9,259,428 |
GlaxoSmithKline Consumer Healthcare Holdings (US), LLC v. Cipla Ltd., IPR2020-00371 (PTAB) |
Jan. 31, 2020 |
N/A |
Dymista® (azelastine HCl / fluticasone propionate metered spray) |
9,901,585 |
Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms. Inc., 20-0019 (N.D.W.V.) |
Feb. 5, 2020 |
Hon. Irene M. Keeley |
Tradjenta® (linagliptin tablets) |
9,486,526 |
Boehringer Ingelheim Pharms. Inc. v. Aurobindo Pharma Ltd., 20-0023 (N.D.W.V.) |
Feb. 5, 2020 |
Hon. John Preston Bailey |
Tradjenta® (linagliptin tablets) |
9,486,526 |
Gilead Sciences, Inc. v. Apotex, Inc., 20-0189 (D. Del.) |
Feb. 7, 2020 |
Hon. Maryellen Noreika |
Vemlidy® (tenofovir alafenamide tablets) Descovy® (emtricitabine / tenofovir alafenamide tablets) Odefsey® (emtricitabine / rilpivirine / tenofovir alafenamide tablets) |
7,390,791
7,803,788
8,754,065
9,296,769 |
American Regent, Inc. v. Pharmacosmos Therapeutics Inc., 20-1350 (D.N.J.) |
Feb. 7, 2020 |
Hon. Brian R. Martinotti |
Monoferric® (ferric derisomaltose for injection) |
8,431,549
10,478,450 |
Allergan Sales, LLC v. Breckenridge Pharm., Inc., 20-0199 (D. Del.) |
Feb. 10, 2020 |
Hon. Mitchell S. Goldberg |
Saphris® (asenapine maleate sublingual tablets) |
5,763,476 |
AstraZeneca AB v. Alembic Pharms. Ltd., 20-0202 (D. Del.) |
Feb. 11, 2020 |
Hon. Richard G. Andrews |
Tagrisso® (osimertinib mesylate tablets) |
10,183,020 |
Vifor (Int’l) AG v. Mylan Labs. Ltd., 20-1647 (D.N.J.) |
Feb. 14, 2020 |
Hon. Freda L. Wolfson |
Injectafer® (ferric carboxymaltose for injection) |
10,519,252 |
Vifor (Int’l) AG v. Sandoz Inc., 20-1649 (D.N.J.) |
Feb. 14, 2020 |
Hon. Freda L. Wolfson |
Injectafer® (ferric carboxymaltose for injection) |
10,519,252 |
Vanda Pharms. Inc. v. MSN Pharms. Inc., 20-0235 (D. Del.) |
Feb. 19, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,376,487 |
Astellas US LLC v. Int’l Medication Systems, Ltd., 20-0273 (D. Del.) |
Feb. 25, 2020 |
Hon. Colm F. Connolly |
Lexiscan® (regadenoson for injection) |
8,106,183
RE47,301
8,524,883 |
Boehringer Ingelheim Pharms. Inc. v. Annora Pharma Private Ltd., 20-0277 (D. Del.) |
Feb. 25, 2020 |
Hon. Colm F. Connolly |
Glyxambi® (empagliflozin / linagliptin tablets) |
10,258,637 |
Millennium Pharms., Inc. v. Sun Pharm. Indus. Ltd., 20-0289 (D. Del.) |
Feb. 27, 2020 |
Hon. Colm F. Connolly |
Ninlaro® (ixazomib citrate capsules) |
7,442,830
8,859,504
9,175,017 |
ViiV Healthcare Co. v. Lupin Ltd., 20-0293 (D. Del.) |
Feb. 28, 2020 |
Hon. Mitchell S. Goldberg |
Juluca® (dolutegravir sodium / rilpivirine HCl tablets) |
9,242,986
10,426,780 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-0300 (D. Del.) |
Feb. 28, 2020 |
Hon. Leonard P. Stark |
Xeljanz® (tofacitinib citrate tablets) |
6,965,027
7,301,023
RE41,783 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-0301 (D. Del.) |
Feb. 28, 2020 |
Hon. Leonard P. Stark |
Xeljanz XR® (tofacitinib extended-release tablets) |
6,965,027
7,301,023
RE41,783 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-2222 (D.N.J.) |
Feb. 28, 2020 |
Hon. Freda L. Wolfson |
Xeljanz XR® (tofacitinib extended-release tablets) |
6,965,027
7,301,023
RE41,783 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-2227 (D.N.J.) |
Feb. 28, 2020 |
Hon. Freda L. Wolfson |
Xeljanz® (tofacitinib citrate tablets) |
6,965,027
7,301,023
RE41,783 |
Vanda Pharms. Inc. v. MSN Pharms. Inc., 20-0318 (D. Del.) |
Mar. 3, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,449,176 |
Takeda Pharms. U.S.A., Inc. v. Alkem Labs. Ltd., 20-0325 (D. Del.) |
Mar. 3, 2020 |
Hon. Richard G. Andrews |
Colcrys® (colchicine tablets)) |
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722 |
Encore Dermatology Inc. v. Glenmark Pharms. Ltd., 20-2509 (D.N.J.) |
Mar. 6, 2020 |
Hon. Kevin McNulty |
Impoyz® (clobetasol propionate cream) |
9,956,231 |
Astellas US LLC v. Gland Pharma Ltd., 20-0347 (D. Del.) |
Mar. 9, 2020 |
Hon. Colm F. Connolly |
Lexiscan® (regadenoson for injection) |
8,106,183
RE47,301
8,524,883 |
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., 20-2576 (D.N.J.) |
Mar. 10, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Celgene Corp. v. Apotex Inc., 20-2593 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Breckenridge Pharm., Inc., 20-2597 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Hetero Labs Ltd., 20-2601 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Aurobindo Pharma Ltd., 20-2606 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Dr. Reddy’s Labs., Ltd., 20-2607 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Mylan Pharms. Inc., 20-2608 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Celgene Corp. v. Teva Pharms. USA, Inc., 20-2614 (D.N.J.) |
Mar. 10, 2020 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
10,555,939 |
Bausch Health US, LLC v. Aleor Dermaceuticals Ltd., 20-2735 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Alkem Labs. Ltd., 20-2737 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Aurobindo Pharma USA Inc., 20-2738 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Amneal Pharms. LLC v. Cubist Pharms. LLC, IPR2020-00193 (PTAB) |
Nov. 27, 2019 |
N/A |
Cubicin RF® (daptomycin for injection) |
9,138,456 |
Bausch Health US, LLC v. KVK-Tech, Inc., 20-2742 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Lupin Ltd., 20-2744 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Strides Pharma Inc., 20-2746 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Taro Pharms. U.S.A., Inc., 20-2747 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Zydus Pharms. (USA) Inc., 20-2748 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Bausch Health US, LLC v. Mylan Pharms. Inc., 20-2749 (D.N.J.) |
Mar. 12, 2020 |
Hon. Brian R. Martinotti |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Merck Sharp & Dohme B.V. v. Gland Pharma Ltd., 20-2750 (D.N.J.) |
Mar. 12, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Merck Sharp & Dohme B.V. v. Teva Pharms. USA, Inc., 20-2751 (D.N.J.) |
Mar. 12, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Braintree Labs., Inc. v. Alkem Labs. Ltd., 20-0362 (D. Del.) |
Mar. 13, 2020 |
Hon. Colm F. Connolly |
Suprep® Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate oral lavage solution) |
6,946,149 |
Merck Sharp & Dohme B.V. v. Lupin Ltd., 20-2786 (D.N.J.) |
Mar. 13, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Merck Sharp & Dohme B.V. v. Mankind Pharma Ltd., 20-2787 (D.N.J.) |
Mar. 13, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733
6,949,527 |
Bausch Health US, LLC v. Mylan Pharms. Inc., 20-0046 (N.D.W.V.) |
Mar. 13, 2020 |
Hon. Irene M. Keeley |
Jublia® (efinaconazole topical solution) |
10,512,640
10,342,875
10,478,601 |
Exela Pharma Sciences, LLC v. Eton Pharms., Inc., 20-0365 (D. Del.) |
Mar. 16, 2020 |
Hon. Maryellen Noreika |
Elcys® (cysteine HCl for injection) |
10,478,453
10,583,155 |
Merck Sharp & Dohme B.V. v. Fresenius Kabi USA, LLC, 20-2892 (D.N.J.) |
Mar. 16, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Braintree Labs., Inc. v. Alkem Labs. Ltd., 20-2904 (D.N.J.) |
Mar. 16, 2020 |
Hon. Peter G. Sheridan |
Suprep® Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate oral lavage solution) |
6,946,149 |
Merck Sharp & Dohme B.V. v. Dr. Reddy’s Labs., Inc., 20-2909 (D.N.J.) |
Mar. 16, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Merck Sharp & Dohme B.V. v. Fisiopharma S.R.L., 20-2964 (D.N.J.) |
Mar. 17, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Merck Sharp & Dohme B.V. v. Sun Pharm. Indus., Inc., 20-3007 (D.N.J.) |
Mar. 18, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Hoffmann-La Roche, Inc. v. Fresenius Kabi USA, LLC, 20-0394 (D. Del.) |
19-Mar-20 |
Hon. Richard G. Andrews |
Alcensa® (alectinib HCl capsules) |
9,126,931
9,440,922
9,365,514
10,350,214 |
Merck Sharp & Dohme B.V. v. Zydus Pharms. (USA) Inc., 20-3068 (D.N.J.) |
Mar. 19, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Merck Sharp & Dohme B.V. v. USV Private Ltd., 20-3072 (D.N.J.) |
Mar. 19, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Pharmacyclics LLC v. Sun Pharma Global FZE, 20-0403 (D. Del.) |
Mar. 20, 2020 |
Hon. Colm F. Connolly |
Imbruvica® (ibrutinib tablets) |
10,478,439 |
Mitsubishi Tanabe Pharma Corp. v. Aurobindo Pharma USA, Inc. 20-3102 (D.N.J.) |
Mar. 20, 2020 |
Hon. Renee Marie Bumb |
Invokamet XR® (canagliflozin / metformain HCl extended-release tablets) |
7,943,582
8,513,202 |
Mitsubishi Tanabe Pharma Corp. v. Aurobindo Pharma USA, Inc. 20-3106 (D.N.J.) |
Mar. 20, 2020 |
Hon. Freda L. Wolfson |
Invokamet XR® (canagliflozin / metformain HCl extended-release tablets) |
7,943,788
8,222,219
8,785,403 |
Merck Sharp & Dohme B.V. v. Aspiro Pharma Ltd., 20-3112 (D.N.J.) |
Mar. 20, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733
6,949,527 |
Merck Sharp & Dohme B.V. v. Sandoz Inc., 20-3117 (D.N.J.) |
Mar. 20, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Cubist Pharms. LLC v. Mylan Pharms Inc., 20-3168 (D.N.J.) |
Mar. 23, 2020 |
Hon. Brian R. Martinotti |
Cubicin RF® (daptomycin for injection) |
9,138,456 |
Novartis Pharms. Corp. v. Lupin Atlantis Holdings, S.A., 20-0415 (D. Del.) |
Mar. 24, 2020 |
Hon. Leonard P. Stark |
Entresto® (sacubitril / valsartan tablets) |
8,101,659
8,796,331
8,877,938
9,388,134 |
Cubist Pharms. LLC v. Mylan Pharms. Inc., 20-0052 (N.D.W.V.) |
Mar. 24, 2020 |
Hon. Irene M. Keeley |
Cubicin RF® (daptomycin for injection) |
9,138,456 |
Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc., 20-3229 (D.N.J.) |
Mar. 25, 2020 |
Hon. Michael A. Shipp |
Sprycel® (dasatinib tablets) |
7,491,725 |
Merck Sharp & Dohme B.V. v. Mylan API US LLC, 20-3270 (D.N.J.) |
Mar. 25, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Salix Pharms., Ltd. v. Norwich Pharms., Inc., 20-0430 (D. Del.) |
Mar. 26, 2020 |
Hon. Richard G. Andrews |
Xifaxan® (rifaximin tablets) |
7,045,620
7,612,199
7,902,206
7,906,542
7,915,275
8,158,644
8,158,781
8,193,196
8,309,569
8,518,949
8,642,573
8,741,904
8,829,017
8,835,452
8,853,231
8,946,252
8,969,398
9,271,968
9,421,195
9,629,828
10,314,828
10,335,397
10,456,384 |
Ferring Pharms. Inc. v. Fresenius Kabi USA, LLC, 20-0431 (D. Del.) |
Mar. 26, 2020 |
Hon. Maryellen Noreika |
Firmagon® (degarelix for injection) |
9,579,359
9,415,085
8,841,081
9,877,999
8,828,938 |
Merck Sharp & Dohme B.V. v. MSN Labs. Private Ltd., 20-3314 (D.N.J.) |
Mar. 26, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Mallinckrodt Hospital Products IP Ltd. v. Baxter Healthcare Corp., 20-0434 (D. Del.) |
Mar. 27, 2020 |
Hon. Leonard P. Stark |
Ofirmev® (acetaminophen for injection) |
9,399,012
9,610,265
9,987,238
10,383,834
6,992,218 |